Benzamide

Benzamide

SCHEMBL4408659

CCOCC.NC(=O)c1ccccc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 5/20 0.67
▸ MAPT P10636 3/20 0.67
▸ POLB P06746 1/20 0.67
▸ CYP3A4 P08684 1/20 0.67
▸ TSHR P16473 1/20 0.67
▸ CYP2C19 P33261 1/20 0.67
▸ RECQL P46063 1/20 0.67
▸ BLM P54132 1/20 0.67
▸ PMP22 Q01453 1/20 0.67
▸ HSD17B10 Q99714 1/20 0.67
▸ TDP1 Q9NUW8 1/20 0.67
▸ L3MBTL1 Q9Y468 1/20 0.67
▸ PARP10 Q53GL7 7/20 0.55
▸ PLA2G10 O15496 1/20 0.52
▸ PLA2G2A P14555 1/20 0.52
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ LMNA P02545 1/20 0.46
▸ CES2 O00748 1/20 0.45
▸ CES1 P23141 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terephthalamide SCHEMBL7508921 0.89 PARP10 (0.67) PARP1MAPTPOLBCYP3A4TSHR
Benzamide SCHEMBL28263471 0.88 PARP1 (0.67) PARP1MAPTPOLBCYP3A4TSHR
Benzamide SCHEMBL2401802 0.85 PARP1 (0.76) PARP1MAPTPOLBCYP3A4TSHR
Benzamide SCHEMBL1637053 0.85 PARP1 (0.76) PARP1MAPTPOLBCYP3A4TSHR
Ether SCHEMBL9388847 0.84 CES2 (0.52) PARP1MAPTPOLBCYP3A4TSHR
Benzoic Acid SCHEMBL931656 0.83 TSHR (0.64) MAPTPOLBTSHRMEN1KMT2A
Benzamide SCHEMBL9496452 0.83 PARP1 (0.73) PARP1MAPTPOLBCYP3A4TSHR
Benzophenone SCHEMBL1147390 0.83 ALDH1A1 (0.64) MAPTTDP1L3MBTL1MEN1KMT2A
Benzophenone SCHEMBL1147611 0.83 ALDH1A1 (0.64) MAPTTDP1L3MBTL1MEN1KMT2A
Benzamide SCHEMBL11654359 0.83 PARP1 (0.73) PARP1MAPTPOLBCYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1091420-A Process for the preparation of diphenylamine derivatives YONGXIN MEDICINES AND CHEMICAL (CN) 1994-08-31 — — CN claimed
EP-2046747-A1 SUBSTITUTED AMINOMETHYL BENZAMIDE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-15 — — EP disclosed
US-20080045508-A1 SUBSTITUTED AMINOMETHYL BENZAMIDE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2008-02-21 — — US disclosed
WO-2008002818-A1 SUBSTITUTED AMINOMETHYL BENZAMIDE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2008-01-03 — — WO disclosed
CN-1105100-C Compounds with anti-inflammatory and immunosuppressive activity ITALFARMACO SPA (IT) 2003-04-09 — — CN disclosed
CN-1221403-A Compounds with anti-inflammatory and immunosuppressive activity ITALFARMACO SPA (IT) 1999-06-30 — — CN disclosed
CN-1091420-A Process for the preparation of diphenylamine derivatives YONGXIN MEDICINES AND CHEMICAL (CN) 1994-08-31 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045508-A1 SUBSTITUTED AMINOMETHYL BENZAMIDE COMPOUNDS HNMT, HRH3, HRH4 PARP1 1748/4885MAPT 1233/4885POLB 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback